Search clinical trials for: Administrative databases

Total 627 results

Sanofi

Terminated

Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction (INTENSIVE)

AMI

Canada, Brazil, United States, Argentina, Mexico
Sanofi

Terminated

LEVOS - Levofloxacin and Rifampicin Therapy in the Treatment of OsteoArticular Prothethic Infection

Infection

France
Sanofi

Completed

Initiation and Titration of Amaryl (AMIT KZ)

Diabetes Mellitus, Type 2

Kazakhstan
Sanofi

Terminated

Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood Glucose (PRADO)

Obesity

France, Canada, Brazil, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Bulgaria, Slovakia, Belgium, Czech Republic, Austria, Denmark, Egypt, Finland, Greece, Hungary, Ireland, Israel, Italy, Lithuania, Luxembourg, Mexico, Norway, United Kingdom
Sanofi
Regeneron Pharmaceuticals

Completed

A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients

Neoplasms

Japan
Sanofi

Completed

Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin (OPTIMIZATION)

Diabetes Mellitus, Type 2

China
Sanofi

Completed

Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)

Type 2 Diabetes Mellitus

Korea, Republic of
AstraZeneca

Completed

Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease
AstraZeneca

Completed

Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv

Gastroesophageal Reflux Disease
Sanofi

Completed

Irbesartan and Amlodipine Combination in Controlling Blood Pressure (I-COMBO)

Hypertension

India, Philippines, Taiwan, Korea, Republic of
Sanofi

Completed

Study of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal Cancer

Rectal Neoplasms

Spain
Sanofi

Completed

Study to Evaluate the Mortality Reduction of Enoxaparin in Hospitalized Acutely Ill Medical Receiving Enoxaparin (LIFENOX)

Acute Illness

Brazil, China, India, Malaysia, Philippines, Tunisia, Mexico, Korea, Republic of, Hong Kong
Sanofi

Completed

Comparison of Efficacy and Safety of Rimonabant 5mg/Day or 20mg/Day Versus Placebo in Smoking Cessation (STRATUS-EU)

Smoking Cessation

France, Spain, Sweden, Switzerland, Belgium, Denmark, United Kingdom
Sanofi

Completed

Comparison of Efficacy and Safety of Rimonabant 20mg/Day Versus Placebo in Smoking Cessation (STRATUS-META)

Smoking Cessation

United States
Sanofi

Terminated

Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors (RIALTO)

Obesity | Diabetes Mellitus, Type 2 | Dyslipidemia | Microalbuminuria

Spain
Sanofi

Terminated

High Density Lipoprotein Turnover

Obesity

France, United Kingdom, Finland, Australia
Sanofi

Completed

REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents (REASSURE)

Diabetes Mellitus, Type 2

Australia
Sanofi

Terminated

European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia (ETERNAL)

Obesity | Dyslipidemias

Germany, Netherlands, Turkey, Slovakia, United Kingdom, Finland, Hungary, Ireland, Italy, Norway, Greece, Sweden, Czech Republic, Portugal, Switzerland
Sanofi

Completed

Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Smoking Cessation (STRATUS US)

Smoking Cessation

United States
Sanofi

Completed

Efficacy Study on Cognitive Functions in Schizophrenic Patients (AMIMIND)

Schizophrenia

Hungary
Sanofi

Completed

Comparative Safety and Efficacy Evaluation Between Dermacyd Silver and Glycerine Vegetal Soap Granado Traditional

Hygiene

Brazil
Sanofi

Terminated

Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer (PROSTATA)

Prostatic Neoplasms

Spain
Sanofi

Completed

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year (EPLILONG)

Insomnia | Sleep Initiation and Maintenance Disorders

United States, France, Germany, Netherlands, Spain, Czech Republic, Mexico, United Kingdom, Argentina, Austria, Finland, Chile, Canada, Australia
Sanofi

Completed

Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia

Chronic Pain | Sleep | Fibromyalgia

United States, Canada
Sanofi

Completed

Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes Patients (SUMER)

Diabetes Mellitus, Type 2

Mexico, Guatemala
Sanofi

Completed

Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties (DREAMS)

Sleep Initiation and Maintenance Disorders

France, Netherlands, Portugal, Spain, Estonia, Finland, Norway, Chile
Sanofi

Completed

Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia (PKiDs)

Sleep Initiation and Maintenance Disorders

United States
Sanofi
Bristol-Myers Squibb

Completed

Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS (CURRENT/OASIS7)

Acute Coronary Disease | Angina Unstable

United States, France, Canada, Brazil, Poland, Romania, Russian Federation, Germany, Italy, Netherlands, Sweden, Switzerland, Turkey, Bulgaria, Estonia, India, Malaysia, Singapore, Belgium, Czech Republic, Mexico, Argentina, Chile, Cr... and more
Sanofi

Completed

Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control (LANTIT)

Diabetes Mellitus, Type 2

Turkey
Sanofi

Completed

Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate Cancer (InoPro)

Prostate Cancer | Osteoporosis

Israel
Sanofi
Bristol-Myers Squibb

Completed

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I) (ACTIVE I)

Cardiovascular Disease | Atrial Fibrillation

United States, France, Canada, Brazil, Poland, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Malaysia, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Argentina, Denmark, Finland, Hungary, Norway, United... and more
Sanofi

Completed

Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis (LEADER)

Arthritis, Rheumatoid

Romania, Portugal, Czech Republic, Italy, Korea, Republic of
Sanofi

Completed

Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIA

Sleep Disorders

Mexico
Sanofi

Completed

Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients (EACH)

Carcinoma, Hepatocellular

China, Taiwan, Korea, Republic of, Thailand
Sanofi

Completed

Dermacyd Silver Floral (Lactic Acid) - Compatibility - Stay on Floral

Hygiene

Brazil
Sanofi

Completed

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

Carcinoma, Squamous Cell

Austria
Sanofi

Completed

Dermacyd Silver Floral (Lactic Acid) - Acceptability.

Hygiene

Brazil
Sanofi

Completed

Dermacyd PH_DESILSTY_FL (Lactic Acid) - Acceptability - Stay on Floral.

Hygiene

Brazil
Sanofi

Completed

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Photo Evaluation - Stay on Frutal

Hygiene

Brazil
Sanofi

Completed

Dermacyd Silver Frutal (Lactic Acid) - Acceptability.

Hygiene

Brazil
Sanofi

Completed

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Compatibility - Stay on Frutal

Hygiene

Brazil
Sanofi

Completed

Dermacyd Silver Frutal (Lactic Acid) - Compatibility.

Hygiene

Brazil
Sanofi

Completed

Dermacyd Silver Frutal (Lactic Acid) - Photo Evaluation.

Hygiene

Brazil
Sanofi

Completed

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on Frutal

Hygiene

Brazil
Sanofi

Completed

Dermacyd PH_DESILSTY_FL (Lactic Acid) - Photo Evaluation - Stay on Floral

Hygiene

Brazil
Sanofi

Completed

Dermacyd Silver Floral (Lactic Acid) - Photo Evaluation

Hygiene

Brazil
Sanofi

Completed

Dermacyd Silver Floral (Lactic Acid) - Compatibility.

Hygiene

Brazil
Sanofi
Bristol-Myers Squibb

Completed

Screening DIVA - Diffuse Vascular Disease

Peripheral Vascular Diseases

Canada
Sanofi

Completed

Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes Mellitus (SCALE)

Diabetes Mellitus

Egypt
Sanofi

Completed

Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus (PUMP)

Diabetes Mellitus, Type 1

France, Australia, Spain, Sweden, United States, Austria, Hungary, Israel, Italy, United Kingdom, Korea, Republic of, Netherlands

3

Subscribe